Enhancing recovery from sepsis: a review
HC Prescott, DC Angus - Jama, 2018 - jamanetwork.com
Importance Survival from sepsis has improved in recent years, resulting in an increasing
number of patients who have survived sepsis treatment. Current sepsis guidelines do not …
number of patients who have survived sepsis treatment. Current sepsis guidelines do not …
Acute infection and myocardial infarction
DM Musher, MS Abers… - New England Journal of …, 2019 - Mass Medical Soc
Risk of MI after Acute Infection Among patients who are hospitalized for pneumococcal
pneumonia, the incidence of myocardial infarction is 7 to 8%. The true incidence of …
pneumonia, the incidence of myocardial infarction is 7 to 8%. The true incidence of …
Hydrocortisone, vitamin C, and thiamine for the treatment of severe sepsis and septic shock: a retrospective before-after study
PE Marik, V Khangoora, R Rivera, MH Hooper… - Chest, 2017 - Elsevier
Background The global burden of sepsis is estimated as 15 to 19 million cases annually,
with a mortality rate approaching 60% in low-income countries. Methods In this retrospective …
with a mortality rate approaching 60% in low-income countries. Methods In this retrospective …
Surviving sepsis campaign: research priorities for sepsis and septic shock
CM Coopersmith, D De Backer, CS Deutschman… - Intensive care …, 2018 - Springer
Objective To identify research priorities in the management, epidemiology, outcome and
underlying causes of sepsis and septic shock. Design A consensus committee of 16 …
underlying causes of sepsis and septic shock. Design A consensus committee of 16 …
Septic cardiomyopathy
SJ Beesley, G Weber, T Sarge, S Nikravan… - Critical care …, 2018 - journals.lww.com
Objectives: To describe, with an emphasis on clinical applications, what is known about the
pathophysiology, management, and implications of septic cardiomyopathy in the adult ICU …
pathophysiology, management, and implications of septic cardiomyopathy in the adult ICU …
Early expansion of circulating granulocytic myeloid-derived suppressor cells predicts development of nosocomial infections in patients with sepsis
F Uhel, I Azzaoui, M Grégoire, C Pangault… - American journal of …, 2017 - atsjournals.org
Rationale: Sepsis induces a sustained immune dysfunction responsible for poor outcome
and nosocomial infections. Myeloid-derived suppressor cells (MDSCs) described in cancer …
and nosocomial infections. Myeloid-derived suppressor cells (MDSCs) described in cancer …
Hydrocortisone, ascorbic acid and thiamine (HAT therapy) for the treatment of sepsis. Focus on ascorbic acid
PE Marik - Nutrients, 2018 - mdpi.com
Sepsis is a devastating disease that carries an enormous toll in terms of human suffering
and lives lost. Over 100 novel pharmacologic agents that targeted specific molecules or …
and lives lost. Over 100 novel pharmacologic agents that targeted specific molecules or …
Severe infection and risk of cardiovascular disease: a multicohort study
Background: The excess risk of cardiovascular disease associated with a wide array of
infectious diseases is unknown. We quantified the short-and long-term risk of major …
infectious diseases is unknown. We quantified the short-and long-term risk of major …
Trained immunity and reactivity of macrophages and endothelial cells
Innate immune cells can develop exacerbated immunologic response and long-term
inflammatory phenotype following brief exposure to endogenous or exogenous insults …
inflammatory phenotype following brief exposure to endogenous or exogenous insults …
Understanding long-term outcomes following sepsis: implications and challenges
M Shankar-Hari, GD Rubenfeld - Current infectious disease reports, 2016 - Springer
Sepsis is life-threating organ dysfunction due to infection. Incidence of sepsis is increasing
and the short-term mortality is improving, generating more sepsis survivors. These sepsis …
and the short-term mortality is improving, generating more sepsis survivors. These sepsis …